Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Glenmark Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue1.001.001.001.001.00
      
Net Profit/Loss Before Extraordinary Items And Tax1399.2136.50868.451441.251382.48
      
Net CashFlow From Operating Activities-827.60-265.44625.391108.651131.21
Net Cash Used In Investing Activities2.094560.89-528.49-333.28-675.24
Net Cash Used From Financing Activities787.05-3906.13-77.46-520.49-441.78
Foreign Exchange Gains / Losses55.8917.6812.3917.5513.62
Adjustments On Amalgamation / Merger / Demerger And Others0.00-191.760.670.000.00
      
Net Inc/Dec In Cash And Cash Equivalents17.44215.2432.50272.4327.82
Cash And Cash Equivalents Begin of Year1658.271443.031410.531138.101110.28
Cash And Cash Equivalents End Of Year1675.711658.271443.031410.531138.10
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue1.00
  
Net Profit/Loss Before Extraordinary Items And Tax1399.21
Net CashFlow From Operating Activities-827.60
Net Cash Used In Investing Activities2.09
Net Cash Used From Financing Activities787.05
Foreign Exchange Gains / Losses55.89
Adjustments On Amalgamation / Merger / Demerger And Others0.00
Net Inc/Dec In Cash And Cash Equivalents17.44
Cash And Cash Equivalents Begin of Year1658.27
Cash And Cash Equivalents End Of Year1675.71